HOME >> BIOLOGY >> NEWS
Research on lead poisoning, hair styling and artists oil paints will be featured at Towson University gathering of worlds largest scientific society

rance. (Presenter Gabriela M. Wis-Surel, Unilever Research, Edgewater, NJ)

  • How sunbathing and cosmetic chemical treatments affect hair at molecular level - Exposure to sun, particularly during summer, as well as cosmetic chemical hair treatments, can damage hair fibers. Researchers will discuss the extent of hair damage caused by sun and beauty products and how new research is influencing cosmetic companies to develop sunscreen products for hair. (Presenter Chandra Pande, Clairol Inc., 2 Blachley Road, Stamford, CT)

  • The science of smell: how the nose senses odor - The olfactory system determines how we perceive fragrances and other odors, and also provides neuroanatomical pathways by which odorous compounds affect our memory and emotions. In the nose, odorants bind to an extremely large family of receptors. This binding event initiates a cascade of molecular events culminating in the detection and recognition of an odor by the brain. An independent chemical sensor, the vomeronasal organ, also functions to modulate sexual and aggressive behavior in many animals. The presence of this organ in humans suggests that airborne chemicals may be able to influence human behaviors. (Presenter Jonathan Pevsner, Department of Neurology, Kennedy Krieger Institute, Baltimore, MD)

    Thursday, May 31, 2001
    1:30 p.m. 4:15 p.m.

    • Childhood blood lead surveillance in Maryland - Maryland law requires that laboratories report all blood lead test results on children to the Maryland Childhood Lead Registry. Reported data are the basis for statewide surveillance, case identification, and case tracking. This presentation will demonstrate uses of this data, including: assessment of screening performance, trends in blood lead levels over time, identification of high risk areas,case management, enforcement, and GIS applications. The presentation will also cover a statute recently passed by Maryland state legislat
      '"/>


    Contact: Luana Bossolo
    l_bossolo@acs.org
    202-872-4446
    American Chemical Society
    1-Jun-2001


    Page: 1 2 3

    Related biology news :

    1. Researchers determine genetic cause of Timothy syndrome
    2. Researchers find color sensitive atomic switch in bacteria
    3. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
    4. Researchers identify protein promoting vascular tumor growth
    5. Researchers devise potent new tools to curb ivory poaching
    6. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
    7. Researchers ID chlorophyll-regulating gene
    8. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
    9. Research suggests new avenue for stopping, preventing colon cancer
    10. Researchers develop fast track way to discover how cells are regulated
    11. Research on carbohydrate metabolism receives historical recognition

  • Post Your Comments:
    (Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
    (Date:10/17/2014)... release is available in German . ... of sperms every day in order to reproduce? And why ... the topic of the latest issue of the research journal ... The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld has ... is not unusual for a female to copulate with several ...
    (Date:10/17/2014)... To date, antidotes ... doctors are often limited to supportive therapy such as induced ... of drugs involved. So what can be done if a ... professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences at ... "The task was to develop an agent that could eliminate ...
    Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Sperm wars 2Emergency aid for overdoses 2Emergency aid for overdoses 3
    (Date:10/22/2014)... Oct. 22, 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, announced today that ... Notice of Allowance for a composition of matter patent ... difficile program, SYN-004. This is Synthetic Biologics, first ... U.S. and adds to the Company,s extensive C. ...
    (Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
    (Date:10/20/2014)... 20, 2014 Asterias Biotherapeutics, Inc. (NYSE ... signed a Notice of Grant Award (NGA) with ... October 1, 2014.  The NGA provides for the ... release of additional grant funds pursuant to the ... clinical development of Asterias, product, AST-OPC1. The grant ...
    (Date:10/20/2014)... BOSTON , Oct. 20, 2014 ... commercialization company tackling big healthcare problems, announced today ... investment round, with participation from Invesco Perpetual, a ... be used to drive PureTech,s existing pipeline forward ... technologies. "PureTech has the scientific creativity to really ...
    Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
    Cached News: